Who Paid My Doc
Acp-2566-003
ClinicalTrials.gov NCT04181723
Research payments
$4,247,606
Through program year 2023, $4,247,606 in research payments was reported against Acp-2566-003, across 648 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT04181723
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $119,450 | 18 |
| 2022 | Research | $606,628 | 49 |
| 2021 | Research | $2,462,418 | 137 |
| 2020 | Research | $984,395 | 77 |
| 2019 | Research | $74,715 | 367 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Constance Smith Hicks Baltimore, MD Named on 26 payments
- Elizabeth Berry-Kravis Chicago, IL Named on 25 payments
- Eric Marsh Philadelphia, PA Named on 19 payments
- Daniel Glaze Houston, TX Named on 17 payments
- David Lieberman Boston, MA Named on 17 payments
- Timothy Feyma Saint Paul, MN Named on 13 payments
- Richard Haas San Diego, CA Named on 12 payments
- Robin Ryther Saint Louis, MO Named on 11 payments
- Randi Hagerman Davis, CA Named on 11 payments
- Judith Ranells Tampa, FL Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.